Abstract. Cell interaction with extracellular matrix is a crucial event for various biological processes, including tumor progression. Although not exclusively, these interactions are frequently mediated by bidirectional signaling receptors known as integrins. Using a human histiocytic lymphomaderived cell line (U-937), we evaluated the effects of ECM proteins and their integrin-type receptors in the regulation of cell attachment, proliferation, migration and survival. Fibronectin induces higher cell attachment in vitro when compared to laminin. Fibronectin also promotes a decrease in cell migration but do not modulate cell proliferation and death. Pre-incubation of U-937 cells with VLA-5 antagonistic peptides inhibited attachment of the cells to fibronectincoated substrates. In a second vein, we observed that lymph node specimens obtained from diagnosed patient for true histiocytic lymphoma had greater deposition of fibronectin (but not laminin) around malignant clones. These results suggest that fibronectins play a relevant role in the establishment and progression of true histiocytic lymphoma cells.
Introduction
Cell interaction with extracellular matrix (ECM) is a crucial event for various biological processes, including cell proliferation, differentiation, migration and death, as well as tumor growth and metastasis (1) . The complex process of tumor cell growth and metastasis consists of a series of steps, in which tumor cells progress from cell-cell interactions to cell-ECM interactions mainly involving cell surface adhesion molecules (2) , including, among others, integrins, selectins, members of the immunoglobulin gene superfamily, cadherins and CD44 (3, 4) .
Integrins are a diverse family of glycoproteins that form heterodimeric receptors composed of non-covalently associated α and ß subunits (5) . These molecules are bidirectional signaling receptors which convey information both into and out of the cell (6) . Several integrins of the ß 1 and ß 2 family have been identified in hematopoietic cells. Among ß 1 -integrins, a particular role has been attributed to α4ß1 (CD49d/CD29) and α5ß1 (CD49e/CD29) for the adhesion of hematopoietic cells to fibronectin (FN) (7, 8) . The FN cell-binding domains recognized by these integrins are the alternative spliced segment III CS (CS1) (9) , and the Arg-Gly-Asp (RGD) sequence (10) , respectively. Fibronectin receptors play a critical role in the attachment of hematopoietic progenitors to bone marrow (2) . Additionally, these interactions can result in signal transduction that can alter proliferation and apoptosis in leukocytes (7) (8) (9) (10) (11) .
It has been shown that in leukemia, the aberrant expression of integrins is related to infiltration in bone marrow and lymph nodes. In chronic myeloid leukemia, abnormal trafficking of malignant progenitors may be related to impaired α4ß1 and α5ß1 integrin-mediated adhesion to stromal cells and FN, as well as abnormal mobility onto FN substrates (12) .
In the context of integrin-ECM interactions, invasive cells can exhibit selective targeting to specific locations in the host. For the true histiocytic lymphoma (THL), lymph nodes, gastrointestinal tract, skin, and soft tissues are common sites of infiltration (13) . THL is a rare aggressive non-Hodgkin's lymphoma (<0.5% of NHLs) with a very poor outcome. It is Is there a role for fibronectin upon true histiocytic lymphoma progression?
composed of neoplastic cells with variable morphology, with immunophenotypic evidence of histiocytic differentiation (14, 15) . This tumor frequently has an aggressive behavior and is preferentially localized, but may occur as a disseminated disease (16, 17) . Clinical features include weight loss, fever, lymphadenopathy and splenomegaly. The gastrointestinal tract is the most frequent extranodal localization. Infiltration of neoplastic cells is observed in central nervous system, bone, skin, lung, liver, kidney, bone marrow and soft tissues (16, 18) . In lymph nodes, neoplastic cells tend to surround the sinuses, where they can be immunohistochemically revealed with one or more histiocytic markers: CD68, lysozyme and α-1 anti-trypsin (15) . We investigated herein the role of fibronectin in the behavior of the U937 THL cell line, and correlated the degree of fibronectin deposition in lymph nodes from a THL patient.
Materials and methods
Reagents. RPMI-1640 culture medium, bovine serum albumin (BSA), penicillin, streptomycin, L-glutamine, propidium iodide solution, human plasma fibronectin and EHS murine sarcoma derived laminin were purchased from Sigma (Saint Louis, MO, USA), whereas fetal calf serum (FCS), EDTA and the CellTrace' CFSE cell proliferation kit were from Invitrogen (Carlsbad, CA, USA). The antibodies anti-CD49d-PE (anti-VLA-4; clone 9F10), anti-CD49e-PE (anti-VLA-5; clone IIA1), anti-CD49f-PE (anti-VLA-6; clone GoH3), anti-CD29-PE-Cy5 (clone MAR4), as well as the controls anti-mouse IgG 1 -PE (clone MOPC-21), anti-mouse IgG 1 -PE-Cy5 (clone MOPC-31C) and anti-rat IgG 2a -PE (clone R35-95) were purchased from Becton-Dickinson/ Pharmingen (San Diego, CA, USA) whereas polyclonal rabbit anti-human laminin (code Z0097) and anti-human fibronectin (code A0245), immune sera, LSAB + ™ kit and liquid diaminobenzidine (DAB) were from Dako (Carpinteria, CA, USA). The apoptosis detection kit was from (R&D Systems, Minneapolis, MN, USA) and the peptides GRGDSP (RGD peptide), EILDVPST (CS-1 peptide) and GRGESP (control RGE peptide) were synthesized by Invitrogen (EvoQuest™ Laboratory Services, Carlsbad, CA, USA).
Cell culture. The human histiocytic lymphoma cell line U-937 (19) was obtained from the Rio de Janeiro Cell Bank (Federal University of Rio de Janeiro). Cells were grown under standard cell culture conditions, in RPMI-1640 medium containing 2x10 -3 M L-glutamine, 100 UI/l penicillin/streptomycin, and supplemented with 10% (v/v) heat-inactivated fetal calf serum, in 25 cm 2 flasks (Costar, Cambridge, MA, USA). Growth and morphology were checked twice a week and the cells used for experimentation were at the third culture passage.
Flow cytometric analysis. Detection of ECM receptors on U-937 cell membrane was carried out by cytofluorometry as described elsewhere (20) . Cells (10 6 viable cells per well) were plated in 96-well microplates (Nalge Nunc International, Naperville, USA). Cell suspensions were first incubated with purified mouse IgG (used for blocking Fc receptors), and subjected to anti-CD49d-PE, anti-CD49e-PE, anti-CD49f-PE or anti-CD29-PE-Cy5 mAb, or to the corresponding IgGmatched negative controls. Cells were ultimately analyzed using a FACScalibur apparatus (Becton Dickinson, San Jose, CA, USA). A cell gate excluding cell debris and non-viable cells was determined using forward and side scatter parameters, and was confirmed in some experiments with the use of propidium iodide staining and immediate analysis of unfixed cells. Analyses were done after recording at least 10,000 events for each sample.
Cell adhesion assay. To assess the adhesive capacity of U-937 cells on ECM substrata, cells were washed, and submitted to a cell adhesion assay on plates (24-well plates, Nalge Nunc International) pre-coated with 10 μg/ml FN, laminin or BSA overnight at 4˚C, as previously described (21) . The wells were washed three times with adhesion buffer (0.5% BSA in RPMI-1640 medium) and blocked with RPMI-1640 containing 1% BSA for 1 h at 37˚C. Cells were them added to the wells (2x10 5 cells per well in 500 μl adhesion buffer) for 1 h at 37˚C, followed by 30 min of incubation under shaking (60 rpm). After further washing to remove nonadherent cells, adherent cells were detached with ice-cold RPMI-1640 containing 5 mM EDTA and counted in a hemocytometer. When testing for peptide blocking activity, U-937 cells were pre-incubated in the presence of soluble peptides (RGD, CS-1, RGD and CS-1 or RGE; 500 μg/ml) for 1 h in ice bath, before adhesion to FN.
Cell proliferation assay. Labeling of U-937 cells with carboxyfluorescein diacetate succinimidyl ester (CFSE) was performed as described previously (22) with minor modifications. In brief, U937 cells were washed twice and resuspended in prewarmed PBS/0.1% BSA at a final concentration of 1x10 6 cells/ml, then incubated in 1 μM CFSE (Molecular Probes, USA) at 37˚C for 15 min. Cells were washed again before addition to cell proliferation assays on 24-well plates pre-coated with 10 μg/ml BSA or FN. Two hundred thousand cells were added to each well (in 1 ml RPMI-1640) for 1, 24, 48 and 72 h at 37˚C. CFSE-labeled cells were then harvested from individual wells, washed in ice-cold PBS/0,1% BSA, resuspended and fixed in 200 μl 1% paraformaldehyde. Growing cells were ultimately analyzed using a FACScalibur apparatus (Becton Dickinson).
Cell migration assay.
Migration experiments were performed using Transwell plates (6.5 mm diameter and 8 μm pore size; Corning Costar, Cambridge, MA, USA), as currently used in our Laboratory to ascertain fibronectin-driven T cell migration (23) . Both surfaces of the polycarbonate membrane were coated with 10 μg/ml of FN, laminin or BSA for 1 h at 37˚C, followed by 1 h blocking with 1% BSA. Cells (5x10 5 ) were then added to the upper chamber in 100 μl 0.5% BSA/RPMI-1640, and 600 μl 0.5% BSA/RPMI-1640 were added to the lower chamber. After 4-h incubation at 37˚C in 5% CO 2 -containing atmosphere, cells that migrated into lower chambers were removed and counted in a hemocytometer.
Cell survival assay. An apoptosis detection kit (R&D Systems) was used to quantitatively determine U-937 cells undergoing apoptosis by virtue of their ability to bind annexin V and exclude propidium iodide (24) . For the assay, cells (2x10 5 cells per well in 1 ml RPMI-1640) were cultured for 0, 24, 48 and 72 h at 37˚C on plates (24-well plates, Nalge Nunc International), pre-coated with 10 μg/ml FN or BSA and blocked with PBS/1% BSA. Cells were then harvested from individual wells, washed once and resuspended in 100 μl of binding buffer (100 mM HEPES, pH 7.4, containing 1.5 M NaCl, 50 mM KCl, 10 mM MgCl 2 , and 18 mM CaCl 2 ) containing Annexin V FITC and 0.5 μg of propidium iodide for 15 min at room temperature in the dark. Binding buffer was then added to the mixture, and flow cytometry was performed using a FACScalibur apparatus. The percentage of total cells that did not bind propidium iodide or Annexin V-FITC (viable cells), cells that bound Annexin V FITC alone (early apoptosis), or cells that bound both propidium iodide and Annexin V-FITC (late apoptosis or necrosis) was determined, and the results are presented in the form of a density plot.
Lymph node samples. Representative cases of normal and neoplastic lymph nodes were selected from the Hemopathology Laboratory, Santa Catarina Center of Hematology and Hemotherapy (Santa Catarina, Brazil). This study was conducted in accordance with an approved protocol by the institutional review board and the studies were performed in accordance with the Helsinki Declaration of 1975. Cervical lymph node biopsy was performed in a 43-year old male patient, whose clinical examination revealed a bilateral cervical mass, axilar and mediastinal lymphadenomegaly and fever, with no signs of infection. The biopsy showed diffuse altered lymph node architecture with large atypical cells with pleomorphic nuclei, coarse chromatin with one or more nucleoli, and basophilic vacuolated cytoplasm. Flow cytometry and immunohisto- chemistry studies showed cells positive for CD45, CD68, CD15 and lysozyme, and negative for chloracetatesterase and T or B lymphocyte markers (see Fig. 1 for immunohistochemistry) . A diagnosis of a malignant neoplasm with morphological and immunophenotypic features of true histiocytic lymphoma (THL) was ascertained. Control specimens consisted of cervical lymph nodes obtained from patients with negative diagnosis for neoplastic diseases.
Immunohistochemical evaluation. Immunohistochemistry was performed on 4-μm tissue sections previously plated on silane-coated glass slides (Electron Microscopy Sciences, Hatfield, USA). In brief, paraffin tissue sections were treated with xylene and re-hydrated. For the detection of ECM components, slides were subjected for 30 min with 3 μl/ml hydrogen peroxide in methanol to quench endogenous peroxidase activity and then incubated with appropriately diluted antibodies to laminin or fibronectin. Sections were then incubated to the peroxidase-coupled second antibody LSAB + system for 30 min at room temperature. We developed the chromogen with immersion of the slides in a diaminobenzidine-H 2 O 2 substrate for 5 min. The slides were counterstained with haematoxylin, dehydrated and mounted under cover slides.
Statistical analysis. Statistical significance was determined by One-way ANOVA, followed by Newman-Keuls multiple comparison test. Values of p<0.05 were considered significant. Data were expressed as mean ± standard error.
Results

Expression of ß 1 -integrin receptors on U-937 cells and adhesion to corresponding ECM ligands.
U937 cell interactions with proteins of the ECM are mediated, although not exclusively, by different receptors of the ß 1 integrin family (25) . We therefore investigated U937 cells for ß 1 integrin expression using cytofluorometry. As seen in Fig. 2, CD29 (the ß 1 integrin chain) was largely expressed. Accordingly, cells were positive for both fibronectin receptors, although expression of VLA-5 (α5ß1, detected with the anti-CD49e antibody) was clearly higher than that seen for VLA-4 (α4ß1, revealed with the anti-CD49d reagent). These results reveal that the VLA-5 fibronectin receptor is preferentially expressed when compared to VLA-4. The data presented were obtained until the 3rd day of culture, since we noticed that the membrane expression of these integrins decreased after further culturing in serum containing-medium (data not shown).
In order to test cell adhesion abilities to ECM-coated plates, U-937 cells in the third culture passage were used. We observed that in FN-coated plates the adhesion was increased in about 13 to 16 times when compared to adhesion to BSA (Fig. 3A) . Moreover, we observed various cells on the FN-coated plactes, which were spread, exhibiting cytoplasmic processes (Fig. 3B) . The adhesion of cells to laminin-coated plates was not different to the control assays. Colorimetric assay of attached cells had similar results (data not shown).
Pre-incubation of U-937 cells with synthetic peptides inhibited attachment of the cells to FN-coated substrates. More than 70% of U937 cells were unattached in the presence of 500 μg/ml RGD peptide. The mixture of RGD and CS-1 peptides showed a similar inhibitory effect compared with those by RGD peptide alone. Importantly, the CS-1 and the control peptide, RGE, did not block cell adhesion (Fig. 4) . These findings clearly point to the notion that the response of U-937 cells to fibronectin is mediated by VLA-5 rather than VLA-4.
In accordance to the cytofluorometric data, cells derived from long-term cultures (that reduce FN receptor expression) highly decreased the adherence to fibronectin (not shown).
Migration arrest of U-937 cells onto FN substrates.
The ability of a cancer cell to migrate is governed by several factors, and depends on the dynamic interaction with the ECM (26) . Using the transwell migration assay, we compared the effects of ECM proteins on U-937 cell migration. In BSAcoated control inserts, ~10% of the U-937 cells spontaneously migrated after 4 h. When cells were challenged to migrate onto FN-coated inserts, a significant decrease of migration was observed. This was not observed in laminin-coated inserts, where values for cell migration were not different from those seen in the BSA-coated inserts (Fig. 5) .
U-937 cell proliferation and survival on FN substrates.
We monitored U-937 cell proliferation, on ECM-coated plates. Cells initially adhered to FN-coated wells, but no differences in the proliferation rate were observed when cells were cultured onto FN or BSA substrates (Fig. 6) . In early studies it was shown that death of U-937 cells could be induced by serum withdrawal (27). To determine if cell-matrix attachment modulates cell survival under serumdeprivation conditions, cells were plated on 24-well plates coated with fibronectin or BSA and cultured for 24, 48 and 72 h. We found that FN substrate did not alter U-937 cell survival under serum-deprivation conditions when compared to BSA substrate (Fig. 7) .
Increase in fibronectin contents within lymph node of THL patient. Based on in vitro results showing ECM effects on the behavior of a THL cell line, we searched for the ECM deposition in vivo studying a case of THL. We analyzed the sub-capsular region from normal or THL infiltrated lymph nodes. In the THL specimens we found large cells with a more open nuclear chromatin pattern, with one or more prominent centrally-located nucleolus (Fig. 1) . When we analyzed ECM protein staining, we observed in normal lymph nodes, a larger FN deposition in the capsule with a rather weak expression in the cortical region. In THLinfiltrated node a strong FN labeling was observed in the capsule as well as in the cortical region. This was paralleled by reticular fiber deposition around cortical cells, possibly coordinated by malignant infiltration (Fig. 8) . Differently, laminin immunostaining revealed a uniform distribution in capsule and cortex in both control and THL-infiltrated lymph nodes (data not shown).
Discussion
Herein, we demonstrated the role of fibronectin substrate on U-937 histiocytic lymphoma cell line adhesion and migration. We showed that the interaction with fibronectin can strongly adhere and arrest migration of U-937 cells. These responses seems to be mediated specifically by CD49e/CD29 (α5ß1 integrin, VLA-5) rather than CD49d/ CD29 (α4ß1 integrin, VLA-5), since it can be abrogated by the VLA-5 blocking peptide RGD, but not by the CS-1 sequence, which is specifically recognized by VLA-4. This difference is in keeping with the higher membrane expression of CD49e, when compared to CD49d. This correlates to normal tumor progression in which cancer cells invade, attach, remodel the ECM microenvironment and establish on host tissues (5) .
It should be noted however, that although U-937 cells do respond to fibronectin, this ECM component does not seem to be relevant for proliferation or death rescue of these cells in conditions of serum deprivation.
For hematological malignancies, the role of fibronectin can differ: while in some tumors fibronectin induces neoplastic survival and/or development (28,29), in others, its role for malignant progression is not relevant (30). In the case of THL cells, fibronectin does not alter cell growth but appears to modulate cell attachment and migration. This is in keeping with other findings showing that the presence of soluble factors together with fibronectin may regulate cell attachment as well as increase cell migration, that may favor THL malignant infiltration in lymph nodes and in other tissues (31). A second aspect deserving discussion refers to which fibronectin receptor(s) would be involved in FN-driven THL cell responses. In this respect, it has been shown that fibroblast adhesion to LDV sequence of fibronectin via α4ß1 integrin represses α5ß1-mediated interstitial collagenase expression (32). Additionally, fragmentation of fibronectin by plasmin de-repress α5ß1-mediated invasion during wound healing, indicating an important attribute of α4ß1 integrin in regulation α5ß1-induced invasion (33,34). In our studies, it was clear that changes in adhesiveness and migration of U-937 cells after exposure to fibronectin occurred through the VLA-5 receptor, rather than VLA-4.
In connection with the in vitro data, we also observed that lymph nodes infiltrated by THL cells had a greater 
